Chron’s Disease is a chronic inflammatory intestinal disease, first described at the beginning of the last century. The disease is characterized by the alternation of periods of flares and remissions influenced by a complex pathogenesis in which inflammation plays a key role. Crohn’s disease evolution is mediated by a complex alteration of the inflammatory response which is characterized by alterations of the innate immunity of the intestinal mucosa barrier together with a remodeling of the extracellular matrix through the expression of metalloproteins and increased adhesion molecules expression, such as MAcCAM-1. This reshaped microenvironment enhances leucocytes migration in the sites of inflammation, promoting a TH1 response, through the production of cytokines such as IL-12 and TNF-α. IL-12 itself and IL-23 have been targeted for the medical treatment of CD. Giving the limited success of medical therapies, the treatment of the disease is invariably surgical. This review will highlight the role of inflammation in CD and describe the surgical approaches for the prevention of the almost inevitable recurrence.
A) Schema showing regions get affected in Crohn's disease (CD) and
Inflammatory bowel disease
PUFA-Induced Metabolic Enteritis as a Fuel for Crohn's Disease - ScienceDirect
Genetics and pathogenesis of inflammatory bowel disease
Diseases, Free Full-Text
Enfermedad de Crohn, PDF, Digestión
PDF) Pathophysiology of Crohn's disease inflammation and recurrence
Crohn's disease - Wikipedia
Nanomaterials, Free Full-Text
Frontiers Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut–brain communications
A novel framework to build saliva-based DNA methylation biomarkers: quantifying systemic chronic inflammation as a case study
Какво всъщност представлява болестта на Крон? – Нутрима
Is Crohn's an Autoimmune Disease?
Single-cell analysis of Crohn's disease reveals a detailed picture of inflammation in the gut